Evidence map›Paper›PMID 29937993›Full record

ArticleOncotarget2018

Cytogenetic damage analysis in mice chronically exposed to low-dose internal tritium beta-particle radiation.

Sandrine Roch-Lefèvre, Eric Grégoire, Cécile Martin-Bodiot, Matthew Flegal, Amélie Fréneau, Melinda Blimkie, Laura Bannister, Heather Wyatt, Joan-Francesc Barquinero, Laurence Roy and 4 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Sandrine Roch-LefèvreInstitut de Radioprotection et de Sûreté Nucléaire, IRSN, Pôle Santé et Environnement, Direction de la Santé, Fontenay-aux-Roses, France.
Eric GrégoireInstitut de Radioprotection et de Sûreté Nucléaire, IRSN, Pôle Santé et Environnement, Direction de la Santé, Fontenay-aux-Roses, France.
Cécile Martin-BodiotInstitut de Radioprotection et de Sûreté Nucléaire, IRSN, Pôle Santé et Environnement, Direction de la Santé, Fontenay-aux-Roses, France.
Matthew FlegalRadiobiology and Health, Canadian Nuclear Laboratories, Chalk River, Ontario, Canada.
Amélie FréneauInstitut de Radioprotection et de Sûreté Nucléaire, IRSN, Pôle Santé et Environnement, Direction de la Santé, Fontenay-aux-Roses, France.
Melinda BlimkieRadiobiology and Health, Canadian Nuclear Laboratories, Chalk River, Ontario, Canada.
Laura BannisterRadiobiology and Health, Canadian Nuclear Laboratories, Chalk River, Ontario, Canada.
Heather WyattRadiobiology and Health, Canadian Nuclear Laboratories, Chalk River, Ontario, Canada.
Joan-Francesc BarquineroPresent address at: Autonomous University of Barcelona, Faculty of Biosciences, Cerdanyola del Vallès, Spain.
Laurence RoyInstitut de Radioprotection et de Sûreté Nucléaire, IRSN, Pôle Santé et Environnement, Direction de la Santé, Fontenay-aux-Roses, France.
Mohamed BenadjaoudInstitut de Radioprotection et de Sûreté Nucléaire, IRSN, Pôle Santé et Environnement, Direction de la Santé, Fontenay-aux-Roses, France.
Nick PriestRadiobiology and Health, Canadian Nuclear Laboratories, Chalk River, Ontario, Canada.
Jean-René JourdainInstitut de Radioprotection et de Sûreté Nucléaire, IRSN, Direction des Affaires Internationales, Fontenay-aux-Roses, France.
Dmitry KlokovRadiobiology and Health, Canadian Nuclear Laboratories, Chalk River, Ontario, Canada.
Institut de Radioprotection et de Sûreté Nucléaire · FRCanadian Nuclear Laboratories · CAUniversitat Autònoma de Barcelona · ESUniversity of Ottawa · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to carry out a comprehensive examination of potential genotoxic effects of low doses of tritium delivered chronically to mice and to compare these effects to the ones resulting from equivalent doses of gamma-irradiation. Mice were chronically exposed for one or eight months to either tritiated water (HTO) or organically bound tritium (OBT) in drinking water at concentrations of 10 kBq/L, 1 MBq/L or 20 MBq/L. Dose rates of internal β-particle resulting from such tritium treatments were calculated and matching external gamma-exposures were carried out. We measured cytogenetic damage in bone marrow and in peripheral blood lymphocytes (PBLs) and the cumulative tritium doses (0.009 - 181 mGy) were used to evaluate the dose-response of OBT in PBLs, as well as its relative biological effectiveness (RBE). Neither tritium, nor gamma exposures produced genotoxic effects in bone marrow. However, significant increases in chromosome damage rates in PBLs were found as a result of chronic OBT exposures at 1 and 20 M Bq/L, but not at 10 kBq/L. When compared to an external acute gamma-exposure

Indexed as

chroniclegenotoxicitylow-dosetritium exposure

Identifiers

PMID29937993
PMCPMC6007944
OpenAlexW2807038597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.